Intra-Cellular Therapies Inc (NASDAQ:ITCI)
| 59.11 Delayed Data As of Aug 10 |  +2.78 / +4.94%Today’s Change | 28.40 Today|||52-Week Range 66.00 | +12.93% Year-to-Date |
Latest ITCI News | Press Releases
| Intra-Cellular Therapies (ITCI) Reports Q2 Loss, Tops Revenue Estimates Aug 09 / Zacks.com - Paid Partner Content | Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Lags Revenue Estimates Aug 02 / Zacks.com - Paid Partner Content |
| Is a Surprise Coming for Intra-Cellular (ITCI) This Earnings Season? Aug 08 / Zacks.com - Paid Partner Content | Intra-Cellular Therapies (ITCI) Expected to Beat Earnings Estimates: Should You Buy? Aug 01 / Zacks.com - Paid Partner Content |
| Arbutus Biopharma (ABUS) Reports Q2 Loss, Tops Revenue Estimates Aug 04 / Zacks.com - Paid Partner Content |
